MAXIMUM TOLERATED DOSE

Clinical trials for MAXIMUM TOLERATED DOSE explained in plain language.

Never miss a new study

Get alerted when new MAXIMUM TOLERATED DOSE trials appear

Sign up with your email to follow new studies for MAXIMUM TOLERATED DOSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Donor immune cells join fight against advanced throat cancer

Disease control Not yet recruiting

This trial is testing whether adding donor immune cells called Natural Killer (NK) cells to standard chemotherapy and radiation can reduce cancer recurrence in patients with advanced nasopharyngeal cancer. The study will first find the safest dose of these donor cells, then test …

Matched conditions: MAXIMUM TOLERATED DOSE

Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

MAXIMUM TOLERATED DOSE

Get alerted when new MAXIMUM TOLERATED DOSE trials appear

Donor immune cells join fight against advanced throat cancer